AI Signal & Stock Analysis · Strong ↑
As of Oct 5 2026, 3:49 PM, AkshayaAI's signal for PCVX is Strong ↑; the stock is at $73.82 (+30.70% today); overbought (RSI 77); technical trend is Raise; news sentiment is negative.
Data as of Oct 5 2026, 3:49 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Strong ↑ |
|---|---|
| Price | $73.82 |
| Change today | +30.70% |
| RSI (14) | 76.59 |
| Relative volume | 12.82 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $11.0B |
| Forward P/E | 0.00 |
| 52-week high | 13.6% away |
| 52-week low | +85.2% above |
| Technical trend | RAISE-2026-10-05 |
| News sentiment | Negative |
| Sector | Healthcare-Biotech |
| Next earnings | 8/5/2026 4:30:00 PM |
As of Oct 5 2026, 3:49 PM, AkshayaAI assigns PCVX (Vaxcyte Inc) a Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
PCVX's RSI is overbought (RSI 77). A reading above 70 is typically considered overbought and below 30 oversold.
PCVX is trading about 14% below its 52-week high and 85% above its 52-week low as of Oct 5 2026, 3:49 PM.
PCVX's next earnings date is 8/5/2026 4:30:00 PM.
PCVX is classified under Healthcare-Biotech in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for PCVX — not personalised investment advice. Always do your own research.
VRTX · REGN · ARGX · RVMD · ONC · RPRX
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Oct 5 2026, 3:49 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.